骨髓细胞中的巨细胞病毒与外周血白细胞中的巨细胞病毒相关。
Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes.
作者信息
Capobianchi Angela, Iori Anna Paola, Micozzi Alessandra, Torelli Giovanni Fernando, Testi Anna Maria, Girmenia Corrado, Santilli Stefania, Barberi Walter, Antonelli Guido, Foà Robin, Gentile Giuseppe
机构信息
Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
Department of Molecular Medicine, Sapienza University, Rome, Italy.
出版信息
J Clin Microbiol. 2014 Jun;52(6):2183-5. doi: 10.1128/JCM.00702-14. Epub 2014 Mar 26.
Abstract
In allogeneic hematopoietic stem cell transplant recipients with bone marrow (BM) suppression, cytomegalovirus (CMV) pp65 antigenemia and DNA were detectable in peripheral blood leukocytes (PBL) and BM cells. A relationship between CMV infection of PBL and BM cells has been found.
摘要
在患有骨髓抑制的异基因造血干细胞移植受者中，外周血白细胞（PBL）和骨髓细胞中可检测到巨细胞病毒（CMV）pp65抗原血症和DNA。已发现PBL和骨髓细胞的CMV感染之间存在关联。
相似文献
1
Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes.骨髓细胞中的巨细胞病毒与外周血白细胞中的巨细胞病毒相关。
J Clin Microbiol. 2014 Jun;52(6):2183-5. doi: 10.1128/JCM.00702-14. Epub 2014 Mar 26.
2
Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.肾移植患者有症状巨细胞病毒（CMV）感染的早期诊断：血浆中CMV DNA扩增与白细胞中CMV pp65抗原（ppUL83）检测的比较
Clin Diagn Virol. 1996 Nov;7(2):99-110. doi: 10.1016/s0928-0197(96)00258-9.
3
4
Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.通过pp65抗原血症和实时定量DNA PCR检测评估实体器官移植受者的巨细胞病毒载量：与pp67 RNA检测的相关性
J Med Virol. 2004 Sep;74(1):78-84. doi: 10.1002/jmv.20149.
5
Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR.通过实时聚合酶链反应对骨髓移植受者的人巨细胞病毒DNA进行定量分析。
J Clin Microbiol. 2001 Dec;39(12):4362-9. doi: 10.1128/JCM.39.12.4362-4369.2001.
6
Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.在异基因骨髓移植后，使用pp65抗原血症检测法、CMV核酸扩增检测法以及半定量聚合酶链反应检测法分析巨细胞病毒（CMV）病毒血症。
Transpl Infect Dis. 2007 Mar;9(1):16-21. doi: 10.1111/j.1399-3062.2006.00171.x.
7
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.一项前瞻性研究，比较血浆中巨细胞病毒（CMV）定量聚合酶链反应和pp65抗原血症检测在监测异基因干细胞移植患者中的作用。
BMC Infect Dis. 2006 Nov 21;6:167. doi: 10.1186/1471-2334-6-167.
8
9
Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients.流式细胞术直接定量检测实体器官和干细胞移植受者 pp65 抗原血症的临床相关性。
J Clin Microbiol. 2000 Sep;38(9):3143-9. doi: 10.1128/JCM.38.9.3143-3149.2000.
10
A simplified cytomegalovirus pp65 antigenemia assay procedure.一种简化的巨细胞病毒pp65抗原血症检测程序。
J Clin Virol. 2003 Dec;28(3):317-22. doi: 10.1016/s1386-6532(03)00075-1.
引用本文的文献
1
The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia.在获得性再生障碍性贫血的单倍体相合造血干细胞移植中，继发性不良移植物功能的发生率、结局和危险因素。
Front Immunol. 2022 May 9;13:896034. doi: 10.3389/fimmu.2022.896034. eCollection 2022.
2
Pp65 antigenemia and cytomegalovirus diagnosis in patients with lupus nephritis: report of a series.狼疮性肾炎患者的pp65抗原血症与巨细胞病毒诊断：系列病例报告
J Bras Nefrol. 2018 Jan-Mar;40(1):44-52. doi: 10.1590/2175-8239-JBN-3838. Epub 2018 Apr 26.
本文引用的文献
1
Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.在抢先治疗时代，巨细胞病毒胃肠道疾病对胃肠道移植物抗宿主病患者临床结局的影响。
Ann Hematol. 2013 Apr;92(4):497-504. doi: 10.1007/s00277-012-1632-x. Epub 2012 Nov 20.
2
Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.基于病毒载量的、风险适应的、先发制人的治疗策略在造血细胞移植后预防巨细胞病毒病的疗效。
Biol Blood Marrow Transplant. 2012 Nov;18(11):1687-99. doi: 10.1016/j.bbmt.2012.05.015. Epub 2012 Jun 7.
3
Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.异基因造血细胞移植后第 28 天以后的细胞减少症：受者/供者因素、移植条件和骨髓毒性药物的影响。
Haematologica. 2011 Dec;96(12):1838-45. doi: 10.3324/haematol.2011.044966. Epub 2011 Aug 31.
4
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response.全血与血浆巨细胞病毒病毒载量检测在监测治疗反应中的临床应用。
Transplantation. 2011 Jan 27;91(2):231-6. doi: 10.1097/TP.0b013e3181ff8719.
5
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.一项前瞻性研究，比较血浆中巨细胞病毒（CMV）定量聚合酶链反应和pp65抗原血症检测在监测异基因干细胞移植患者中的作用。
BMC Infect Dis. 2006 Nov 21;6:167. doi: 10.1186/1471-2334-6-167.
6
Cytomegalovirus mediated myelosuppression.巨细胞病毒介导的骨髓抑制。
J Clin Virol. 2002 Aug;25 Suppl 2:S51-6. doi: 10.1016/s1386-6532(02)00092-6.
7
The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease.在患有巨细胞病毒（CMV）疾病的移植受者中，利用各种血液成分进行CMV DNA定量的临床应用。
Transplantation. 2002 Mar 27;73(6):968-73. doi: 10.1097/00007890-200203270-00025.
8
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.应用病毒载量动力学来识别移植后发生巨细胞病毒疾病的患者。
Lancet. 2000 Jun 10;355(9220):2032-6. doi: 10.1016/S0140-6736(00)02350-3.
9
Occult cytomegalovirus infection of marrow stroma.骨髓基质的隐匿性巨细胞病毒感染
Clin Infect Dis. 1998 Jan;26(1):209-10. doi: 10.1086/517022.
10
Zotero 插件